Scholar Rock Holding Corp (SRRK)
12.48
-1.84
(-12.85%)
USD |
NASDAQ |
May 17, 16:00
11.85
-0.63
(-5.05%)
After-Hours: 20:00
Scholar Rock Free Cash Flow: -152.02M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -152.02M |
| December 31, 2023 | -145.30M |
| September 30, 2023 | -136.97M |
| June 30, 2023 | -131.21M |
| March 31, 2023 | -133.83M |
| December 31, 2022 | -133.76M |
| September 30, 2022 | -137.73M |
| June 30, 2022 | -148.61M |
| March 31, 2022 | -146.19M |
| December 31, 2021 | -132.04M |
| September 30, 2021 | -120.70M |
| June 30, 2021 | -108.54M |
| March 31, 2021 | -95.64M |
| Date | Value |
|---|---|
| December 31, 2020 | -64.36M |
| September 30, 2020 | -60.24M |
| June 30, 2020 | -50.49M |
| March 31, 2020 | -47.59M |
| December 31, 2019 | -66.23M |
| September 30, 2019 | 5.70M |
| June 30, 2019 | 11.57M |
| March 31, 2019 | 16.93M |
| December 31, 2018 | 23.08M |
| September 30, 2018 | -37.49M |
| June 30, 2018 | -33.66M |
| March 31, 2018 | -27.45M |
| December 31, 2017 | -22.10M |
Free Cash Flow Range, Past 5 Years
-152.02M
Minimum
Mar 2024
11.57M
Maximum
Jun 2019
-99.71M
Average
-125.95M
Median
Free Cash Flow Benchmarks
| Amgen Inc | 7.098B |
| Eli Lilly and Co | -3.896B |
| Ocular Therapeutix Inc | -87.11M |
| Alpine Immune Sciences Inc | -80.96M |
| X4 Pharmaceuticals Inc | -103.71M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -49.78M |
| Cash from Investing (Quarterly) | 33.38M |
| Cash from Financing (Quarterly) | 6.525M |
| Free Cash Flow Per Share (Quarterly) | -0.5194 |
| Free Cash Flow Yield | -13.92% |